섬망 아형의 임상적 의의 = Clinical Implication of Delirium Subtype

다국어 초록 (Multilingual Abstract)

Delirium is a common and serious condition which is often under-detected and under-treated. This may be partly due to a lack of concensus regarding the definition of its subtypes. Subtypes of delirium may be explained according to different pathophysiologic mechanisms. Three subtypes (hyperactive, hypoactive, mixed) of delirium, based on arousal disturbance and psychomotor behavior have been identified. However, definitions may vary from author to author. Irrespective of the way delirium is diagnosed and the subtypes defined, the hypoactive subtype is more prevalent than the hyperactive. Despite this prevalence, a diagnosis of hypoactive delirium is often missed, and rather ismost frequently misdiagnosed as depression or dementla. The hypoactive delirium subtype may be less responsive to antipsychotic drug therapy than the hyperactive delirium subtype. Clinical subtypes of delirium may provide information concerning the etiology, the pathogenesis, and the prognosis of delirium, but also may have therapeutic consequences. There remains no consensus regarding the optimal classification system for delirium subtypes. More studies are needed to isolate two, three, or more delirium subtypes, in terms of predicting factors, outcome predictors, and therapeutic management.

참고문헌 (Reference)

1 Akechi T, "Usage of haloperidol for delirium in cancer patients" 4 : 390-392, 1996

2 Trzepacz PT, "Update on the neuropathogenesis of delirium" 10 : 330-334, 1999

3 Slatkin N, "Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report" 27 : 268-273, 2004

4 Lipowski ZJ, "Transient cognitive disorders (delirium, acute confusional states) in the elderly" 140 : 1426-1436, 1983

5 Pro JD, "The use of the electroencephalogram in the diagnosis of delirium" 38 : 804-808, 1977

6 Moyle J, "The use of propofol in palliative medicine" 10 : 643-646, 1995

7 POSNER JB, "The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy" 39 : 1246-1258, 1960

8 Cutting J, "The role of right hemisphere dysfunction in psychiatric disorders" 160 : 583-588, 1992

9 O'Keeffe S, "The prognostic significance of delirium in older hospital patients" 45 : 174-178, 1997

10 Trzepacz PT, "The neuropathogenesis of delirium. A need to focus our research" 35 : 374-391, 1994

11 Rudberg MA, "The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity" 26 : 169-174, 1997

12 Armstrong SC, "The misdiagnosis of delirium" 38 : 433-439, 1997

13 Breitbart W, "The memorial delirium assessment scale" 13 : 128-137, 1997

14 Inouye SK, "The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients" 97 : 278-288, 1994

15 Morita T, "Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate" 8 : 134-137, 2000

16 Bottomley DM, "Subcutaneous midazolam infusion in palliative care" 5 : 259-261, 1990

17 Flacker JM, "Serum anticholinergic activity changes with acute illness in elderly medical patients" 54 : M12-M16, 1999

18 van der Mast RC, "Serotonin and amino acids: partners in delirium pathophysiology?" 5 : 125-131, 2000

19 Boettger S, "Risperidone in the treatment of hypoactive and hyperactive delirium" 2007

20 Meagher DJ, "Relationship between symptoms and motoric subtype of delirium" 12 : 51-56, 2000

21 Meagher DJ, "Relationship between etiology and phenomenologic profile in delirium" 11 : 146-149, 1998

22 Van der Rijt C, "Quantitative EEG analysis and survival in liver disease" 61 : 502-504, 1985

23 Mercadante S, "Propofol in terminal care" 10 : 639-642, 1995

24 Camus V, "Phenomenology of acute confusional states" 181 : 256-257, 2002

25 Breitbart W, "Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer" 10 : 131-141, 1995

26 de Sousa E, "Midazolam in terminal care" 1 : 67-68, 1988

27 Soininen H, "Longitudinal EEG spectral analysis in early stage of Alzheimer's disease" 72 : 290-297, 1989

28 Trzepacz PT, "Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine" 5 : 132-148, 2000

29 Trzepacz PT, "Further analyses of the delirium rating scale" 17 : 75-79, 1995

30 Trzepacz PT, "Further analyses of the delirium rating scale" 17 : 75-79, 1995

31 Camus V, "Factor analysis supports the evidence of existing hyperactive and hypoactive subtypes of delirium" 15 : 313-316, 2000

32 Platt MM, "Efficacy of neuroleptics for hypoactive delirium" 6 : 66-67, 1994

33 de Rooij SE, "Delirium subtype identification and the validation of the delirium rating scale--Revised-98 (Dutch version) in hospitalized elderly patients" 21 : 876-882, 2006

34 Marcantonio E, "Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair" 50 : 850-857, 2002

35 Dolan MM, "Delirium on hospital admission in aged hip fracture patients: prediction of mortality and 2-year functional outcomes" 55 : M527-M534, 2000

36 Lipowski ZJ, "Delirium in the elderly patient" 320 : 578-582, 1989

37 Francis J, "Delirium in older patients" 40 : 829-838, 1992

38 Francis J, "Delirium in older patients" 40 : 829-838, 1992

39 Lawlor PG, "Delirium at the end of life: critical issues in clinical practice and research" 284 : 2427-2429, 2000

40 Lipowski ZJ, "Delirium (acute confusional states)" 258 : 1789-1792, 1987

41 O'Keeffe ST, "Clinical significance of delirium subtypes in older people" 28 : 115-119, 1999

42 Sandberg O, "Clinical profile of delirium in older patients" 47 : 1300-1306, 1999

43 Hemmingsen R, "Cerebral blood flow during delirium tremens and related clinical states studied with xenon-133 inhalation tomography" 145 : 1384-1390, 1988

44 Ross CA, "CNS arousal systems: possible role in delirium" 3 : 353-371, 1991

45 Levin HS, "Behavioral sequelae of closed head injury" 35 : 720-727, 1978

46 Breitbart W, "An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients" 43 : 175-182, 2002

47 Boettger S, "An open label trial of aripiprazole in the treatment of delirirum" 2007

48 Liptzin B, "An empirical study of delirium subtypes" 161 : 843-845, 1992

49 Medina JL, "Agitated delirium caused by infarctions of the hippocampal formation and fusiform and lingual gyri: a case report" 24 : 1181-1183, 1974

50 Stiefel F, "Acute confusional states in patients with advanced cancer" 7 : 94-98, 1992

51 Kobayashi K, "A retrospective study on delirium type" 46 : 911-917, 1992